Valiant Organics Limited – Investor Presentation Summary
Key Operational Highlights
- Total production capacity of 80,000 TPA across manufacturing facilities
- Employs 900+ employees across operations
- Operates 6 manufacturing units across 5 locations
- Maintains 5 Zero Liquid Discharge plants for environmental compliance
- Diversified client base across pharmaceuticals, dyes & pigments, agrochemicals, and specialty chemicals
Key drivers of operational performance: Focus on manufacturing specialty chemicals with high demand but low supply that are primarily import-dependent
Segment-wise Performance
Not Specified
Financial Highlights
- Market capitalization: ₹567 crore as on March 31, 2026
Comparison to market estimates: Not Specified
Key Risks: Not Specified
Geographical Revenue Split
Not Specified
Balance Sheet Snapshot
Not Specified
Capex & Cash Flow Health
Not Specified
Strategic & R&D Initiatives
- Key chemistries include Chlorination, Hydrogenation, Ammonolysis, Acetylation, Sulphonation, Methoxylation
- One of the largest chlorophenol derivatives manufacturers globally
- One of the largest domestic PNA manufacturers
- Among first few domestic PAP manufacturers
- One of the leading manufacturers of Benzene derivatives products
- One of the few commercial players in Ortho Anisidine and Para Anisidine
Industry Trends & Business Environment
Not Specified
Management Commentary & Growth Outlook
Not Specified
Additional Information
- Company incorporated in 1984 by first generation technocrats
- Headquarters located in Mumbai, India
- Listed on both BSE and NSE
- Material step-down subsidiary Valiant Laboratories Limited became an associate company w.e.f. October 04, 2023 after IPO dilution reduced stake to 46.83%
- Previous periods and YTD results are not comparable due to this structural change
- Presentation made at 21st Annual General Meeting held on September 29, 2026
- Filed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015